Literature DB >> 16792533

Soluble HLA-G molecules induce apoptosis in natural killer cells.

Amy Lindaman1, Amy Dowden, Nicholas Zavazava.   

Abstract

Membrane-bound human leukocyte antigen-G (HLA-G) molecules are primarily expressed by cytotrophoblasts of the fetus. They are thought to protect the fetus from immunologic attack by the maternal immune system and have recently been associated with transplantation graft acceptance. In addition, soluble HLA-G molecules (sHLA-G) have been shown to play a role in the success of pregnancies, but are upregulated in certain cancers. However, the exact mechanism for this regulation has remained elusive. The aim of this study was to examine the mechanism by which sHLA-G interact with natural killer (NK) cells in vitro. sHLA-G effectively blocked NK lysis of target cells via fracticide killing of NK cells by apoptosis. These studies support the protective role of sHLA-G in immunologic reactions by interacting with NK cells, thus providing a regulatory function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16792533     DOI: 10.1111/j.1600-0897.2006.00395.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  9 in total

1.  Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus.

Authors:  Adriana Elizabeth Monsiváis-Urenda; Lourdes Baranda; Crisol Alvarez-Quiroga; Carlos Abud-Mendoza; Roberto González-Amaro
Journal:  J Clin Immunol       Date:  2010-12-29       Impact factor: 8.317

2.  sHLA-G involved in the apoptosis of decidual natural killer cells following Toxoplasma gondii infection.

Authors:  Meiyu Han; Yuzhu Jiang; Kaixue Lao; Xiaoyan Xu; Shaowei Zhan; Yanlin Wang; Xuemei Hu
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

3.  HLA-G 14bp Ins/Del Polymorphism, Plasma Level of Soluble HLA-G, and Association with IL-6/IL-10 Ratio and Survival of Glioma Patients.

Authors:  Maria Bucova; Kristina Kluckova; Jan Kozak; Boris Rychly; Magda Suchankova; Marian Svajdler; Viktor Matejcik; Juraj Steno; Eszter Zsemlye; Vladimira Durmanova
Journal:  Diagnostics (Basel)       Date:  2022-04-27

4.  Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.

Authors:  V Jucaud; M H Ravindranath; P I Terasaki; L E Morales-Buenrostro; F Hiepe; T Rose; R Biesen
Journal:  Clin Exp Immunol       Date:  2015-12-16       Impact factor: 4.330

Review 5.  Physiologic Course of Female Reproductive Function: A Molecular Look into the Prologue of Life.

Authors:  Joselyn Rojas; Mervin Chávez-Castillo; Luis Carlos Olivar; María Calvo; José Mejías; Milagros Rojas; Jessenia Morillo; Valmore Bermúdez
Journal:  J Pregnancy       Date:  2015-12-01

Review 6.  Intercellular transfer of HLA-G: its potential in cancer immunology.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Clin Transl Immunology       Date:  2019-08-30

Review 7.  The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.

Authors:  Tobias Bald; Matthew F Krummel; Mark J Smyth; Kevin C Barry
Journal:  Nat Immunol       Date:  2020-07-20       Impact factor: 25.606

8.  Specific and Aspecific Molecular Checkpoints as Potential Targets for Dismantling Tumor Hierarchy and Preventing Relapse and Metastasis Through Shielded Cytolytic Treatments.

Authors:  Giovanni Manzo
Journal:  Front Cell Dev Biol       Date:  2021-07-06

9.  Saliva soluble HLA as a potential marker of response to interferon-beta 1a in multiple sclerosis: a preliminary study.

Authors:  Alireza Minagar; Irena Adamashvili; Roger E Kelley; Eduardo Gonzalez-Toledo; Jerry McLarty; Stacy J Smith
Journal:  J Neuroinflammation       Date:  2007-07-01       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.